Long noncoding RNAs to predict postoperative recurrence in bladder cancer and to develop a new molecular classification system.

The eight-lncRNA signature risk model may be a reliable prognostic signature for MIBC, which provides new insights into prediction of recurrence of MIBC. The model may help clinical decision and eventually benefit patients.